We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

21 hedge funds and large institutions have $899K invested in BIND THERAPEUTICS INC in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more call options, than puts

Call options by funds: $45K | Put options by funds: $3K

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

38% less funds holding

Funds holding: 3421 (-13)

67% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 18

89% less capital invested

Capital invested by funds: $7.84M → $899K (-$6.94M)

Holders
21
Holders Change
-13
Holders Change %
-38.24%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
6
Reduced
2
Closed
18
Calls
$45K
Puts
$3K
Net Calls
+$42K
Net Calls Change
-$210K
Name Holding Trade Value Shares
Change
Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$789K
UBS Group
2
UBS Group
Switzerland
$15K +$27.6K +33,601 +840%
VKH
3
Virtu KCG Holdings
New York
$14K +$28.5K +34,736 New
Millennium Management
4
Millennium Management
New York
$13K +$26.6K +32,451 New
Citadel Advisors
5
Citadel Advisors
Florida
$13K +$26.8K +32,620 New
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$12K +$16.4K +20,000 +200%
Goldman Sachs
7
Goldman Sachs
New York
$11K +$23.7K +28,921 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$10K
FMA
9
FNY Managed Accounts
New York
$9.78K +$2.46K +3,000 +14%
Squarepoint
10
Squarepoint
New York
$4K +$9.03K +11,000 New
Bank of America
11
Bank of America
North Carolina
$3K +$325 +396 +6%
JIC
12
Joel Isaacson & Co
New York
$2K
Creative Planning
13
Creative Planning
Kansas
$1K -$410 -500 -20%
Wells Fargo
14
Wells Fargo
California
$1K
CG
15
Cutler Group
California
$1K +$1.48K +1,800 +180%
Vanguard Group
16
Vanguard Group
Pennsylvania
-$1.09M -495,864 Closed
Renaissance Technologies
17
Renaissance Technologies
New York
-$850K -386,285 Closed
RPAM
18
Rhenman & Partners Asset Management
Sweden
-$294K -133,535 Closed
BCM
19
Bridgeway Capital Management
Texas
-$250K -113,593 Closed
Jacobs Levy Equity Management
20
Jacobs Levy Equity Management
New Jersey
-$198K -89,900 Closed
CS
21
Credit Suisse
Switzerland
-$177K -80,324 Closed
Geode Capital Management
22
Geode Capital Management
Massachusetts
-$131 -59,883 Closed
BFA
23
BlackRock Fund Advisors
California
-$72K -32,627 Closed
HPC
24
HM Payson & Co
Maine
-$66K -30,000 Closed
BA
25
BlackRock Advisors
Delaware
-$44K -19,875 Closed

BIND Hedge Fund Activity: Q2 2016 in Review

21 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q2 2016, worth a combined $899K — down 89% from $7.84M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of BIND and 6 opened new positions — a net loss of 12 holders — while 2 trimmed existing stakes and 6 added.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $28.5K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.09M sold.

  • 21 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q2 2016, down from 34 in Q1 2016.
  • Funds reported $899K of BIND THERAPEUTICS INC stock for Q2 2016, down 89% quarter-over-quarter.
  • 6 funds opened new BIND THERAPEUTICS INC positions in Q2 2016 and 18 closed out, a net change of -12 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q2 2016 was Virtu KCG Holdings, an estimated $28.5K added.
  • The largest BIND THERAPEUTICS INC seller in Q2 2016 was Vanguard Group, an estimated $1.09M sold.

Based on aggregated 13F filings for Q2 2016.